Total Funding
84
66
Total FundingPost-IPO Equity raised
Growth Score 84 in past quarter
-13 pts
Heat Score 66 in past quarter
-24 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17207
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
Acquired by 
Satellos (formerly ICo Therapeutics)
- Antoinette Paone: Chief Development Officer & Head of Regulatory AffairsPast Role: Generation Bio, Chief Operating Officer
- Elizabeth Williams: Chief Financial OfficerPast Role: Medicenna Therapeutics, Chief Financial Officer
About the Company
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration. The company's programs focus on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation.
